Skip to main content Accessibility help
×
Home
Hostname: page-component-56f9d74cfd-fpcrz Total loading time: 1.562 Render date: 2022-06-27T22:03:39.160Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "useRatesEcommerce": false, "useNewApi": true }

Section IV - Contraception and Abortion

Published online by Cambridge University Press:  20 February 2019

David Chelmow
Affiliation:
Virginia Commonwealth University
Nicole W. Karjane
Affiliation:
Virginia Commonwealth University
Hope A. Ricciotti
Affiliation:
Harvard Medical School
Amy E. Young
Affiliation:
University of Texas, Austin
Get access
Type
Chapter
Information
Office Gynecology
A Case-Based Approach
, pp. 64 - 93
Publisher: Cambridge University Press
Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American College of Obstetricians and Gynecologists. Long-Acting Reversible Contraception: Implants and Intrauterine Devices. ACOG Practices Bulletin no 121. American College of Obstetricians and Gynecologists, Washington, DC; 2011. Accessed August 5, 2017.
Heartwell, SF, Schlesselman, S. Risk of uterine perforation among users of intrauterine devices. Obstet Gynecol 1983;61(1):3136.Google ScholarPubMed
Peri, N, Graham, D, Levine, D. Imaging of intrauterine contraceptive devices. Journal of Ultrasound in Medicine 2007;26:13891401.CrossRefGoogle ScholarPubMed
Boortz, HE, Margolis, DJ, Ragavendra, N, Patel, MK, Kadell, BM, Migration of intrauterine devices: radiologic findings and implications for patient care. RadioGraphics 2012; 32(2):335352.CrossRefGoogle ScholarPubMed
Benacerraf, BR, Shipp, TD, Bromley, B. Three dimensional ultrasound detection of abnormally located intrauterine contraceptive devices which are a source of pelvic pain and abnormal bleeding. Ultrasound Obstet Gynecol 2009;34:110115.CrossRefGoogle ScholarPubMed
Nowitzki, KM, Hoimes, ML, Chen, B, Zheng, LZ, Kim, YH. Ultrasonography of intrauterine devices. Ultrasonography 2015;34(3):183194.CrossRefGoogle ScholarPubMed
Madden, T, McNicholas, C, Zhao, Q et al. Association of age and parity with intrauterine device expulsion. Obstet Gynecol 2014;124(4):718726.CrossRefGoogle ScholarPubMed
Uçar, MG, Şanlıkan, F, Ilhan, TT, Göçmen, A, Çelik, Ç. Management of intra-abdominally translocated contraceptive devices, is surgery the only way to treat this problem? J Obstet Gynaecol 2017 May;37(4):480486.CrossRefGoogle ScholarPubMed
World Health Organization: Mechanism of action, safety and efficacy of intrauterine devices. Report of a WHO scientific group. Technical Report Series 753. Geneva, WHO Health Organization, 1987, p. 1–91.[9]
Heinemann, K, Reed, S, Moehner, S, Do Minh, T. Risk of uterine perforation with levonorgestrel – releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices. Contraception 2015;91:274279.CrossRefGoogle Scholar
Phillips, S, Steyn, P, Temmerman, M. Contraceptive options for women living with HIV. Best Pract Res Clin Obstet Gynaecol 2014;28: 881–90.CrossRefGoogle ScholarPubMed
Robinson, JA, Jamshidi, R, Burke, AE. Contraception for the HIV-positive woman: a review of interactions between hormonal contraception and antiretroviral therapy. Infect Dis Obstet Gynecol 2012;2012:115.CrossRefGoogle ScholarPubMed
Amy, JJ, Tripathi, V. Contraception for women: an evidence based overview. BMJ 2009;339:563568.CrossRefGoogle Scholar
Nanda, K, Stuart, G, Robinson, J et al. Drug interactions between hormonal contraceptives and antiretrovirals. AIDS 2017;31:917952.CrossRefGoogle ScholarPubMed
Curtis, KM, Tepper, NK, Jatlaoui, TC et al. U.S. medical eligibility criteria for contraceptive use, 2016. MMWR Recomm Rep 2016;65:1103.Google ScholarPubMed
Polis, CB, Curtis, KM. Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence. The Lancet 2013;13:797807.CrossRefGoogle ScholarPubMed
Phillips, SJ, Polis, CB, Curtis, KM. The safety of hormonal contraceptives for women living with HIV and their sexual partners. Contraception 2016;93:1116.CrossRefGoogle ScholarPubMed
American College of Obstetricians and Gynecologists. Gynecologic care for women and adolescents with human immunodeficiency virus. Practice Bulletin No. 167. Obstet Gynecol 2016;128:e89110.CrossRef
Bhagavan, BS, Gupta, PK. Genital actinomycosis and intrauterine contraceptive devices. Cytopathologic diagnosis and clinical significance. Hum Pathol 1978;9(5):567578.CrossRefGoogle ScholarPubMed
Westhoff, C. IUDs and colonization or infection with Actinomyces. Contraception 2007;75(6 Suppl):S4850.CrossRefGoogle ScholarPubMed
Cheung, ANY et al. Liquid-based cytology and conventional cervical smears: a comparison study in an Asian screening population. Cancer 2003;99(6):331335.CrossRefGoogle Scholar
Kalaichelvan, V, Maw, AA, Singh, K. Actinomyces in cervical smears of women using the intrauterine device in Singapore. Contraception 2006;73(4):352355.CrossRefGoogle ScholarPubMed
Merki-Feld, GS et al. The incidence of actinomyces-like organisms in Papanicolaou-stained smears of copper- and levonorgestrel-releasing intrauterine devices. Contraception 2000;61(6):365368.CrossRefGoogle ScholarPubMed
Carrillo, M et al. In vitro Actinomyces israelii biofilm development on IUD copper surfaces. Contraception 2010;81(3):261264.CrossRefGoogle ScholarPubMed
American College of Obstetricians and Gynecologists. Long acting reversible contraceptives: implants and intrauterine devices. Practice Bulletin 121. Obstet Gynecol 2011;118:186194.
American College of Obstetricians and Gynecologists. Clinical challenges of long-acting reversible contraceptive methods. Committee Opinion 672. Obstet Gynecol 2016;129:e6977.
Muller-Holzner, E et al. IUD-associated pelvic actinomycosis: a report of five cases. Int J Gynecol Pathol 1995;14(1):7074.CrossRefGoogle ScholarPubMed
Nugteren, SK et al. Colitis and lower abdominal mass by Actinomyces israelii in a patient with an IUD. Neth J Med 1996;49(2):7376.CrossRefGoogle Scholar
Center for Disease Control and Prevention. Venous Thromboembolism: Data & Statistics. 2017. www.cdc.gov/ncbddd/dvt/data.html (accessed June 12, 2017.)
Pomp, ER, Lenselink, AM, Rosendaal, FR, Doggen, CJ. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost 2008 April 6;4:632637.CrossRefGoogle Scholar
Heit, JA, Kobbervig, CE, James, AH et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med 2005 November 15. 143(10):697706.CrossRefGoogle ScholarPubMed
Vandenbroucke, Jan P, Rosing, Jan, Kitty, WM et al. Oral contraceptives and the risk of venous thrombosis. N Engl J Med 2001;344:15271535.CrossRefGoogle ScholarPubMed
Lidegaard, O, Lokkegaard, E, Svendsen, AL, Agger, C. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ 2009;339:b2890.CrossRefGoogle ScholarPubMed
Committee on Gynecologic Practice. ACOG Committee Opinion Number 540: risk of venous thromboembolism among users of drospirenone-containing oral contraceptive pills. Obstet Gynecol 2012;120:12391242.
Evidence-Based Medicine Consult. The Mechanism of Oral Contraceptive (Birth Control Pill) Induced Clot or Thrombus Formation (DVT, VTE, PE). 2015. www.ebmconsult.com/articles/oral-contraceptive-clotting-factors-thrombosis-dvt-pe (accessed June 12, 2017).
Curtis, KM, Tepper, NK, Jatlaoui, TC et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Recomm Rep 2016;65(No. RR-3):1104.Google ScholarPubMed
Immediate postpartum long-acting reversible contraception. ACOG Committee Opinion #670, August 2016.
Trussell, J. Contraceptive failure in the United States. Contraception 2011;83(5):397404.CrossRefGoogle ScholarPubMed
Long-acting reversible contraception: implants and intrauterine devices. ACOG Practice Bulletin #121, July 2011.
Mansour, D, Walling, M, Glenn, D et al. Removal of non-palpable etonogestrel implants. J Fam Plann Reprod Health Care April 2014;40:126132.Google Scholar
Mansour, D. Nexplanon: what Implanon did next. J Fam Plann Reprod Health Care October 2010;36:187189.CrossRefGoogle ScholarPubMed
Mansour, D, Fraser, IS, Walling, M et al. Methods of accurate localisation of non-palpable subdermal contraceptive implants. J Fam Plann Reprod Health Care January 2008;34:912.CrossRefGoogle ScholarPubMed
Brown, M, Britton, J. Neuropathy associated with etonogestrel implant insertion. Contraception November 2012;86:591593.CrossRefGoogle ScholarPubMed
Guiahi, M, Tocce, K, Teal, S, Green, T, Rochon, P. Removal of Nexplanon implant located in the biceps muscle using a combination of ultrasound and fluoroscopy guidance. Contraception December 2014;90(6):606608.CrossRefGoogle ScholarPubMed
Pillai, M, Cazet, AC, Griffiths, M. Continuing need for and provision of a service for non-standard implant removal. J Fam Plann Reprod Health Care April 2014;40:126132.CrossRefGoogle ScholarPubMed
Chen, M, Creinin, M. Removal of a nonpalpable etonogestrel implant with preprocedure ultrasonography and modified vasectomy clamp. Obstet Gynecol November 2015;126(5):935938.CrossRefGoogle ScholarPubMed
Curtis, KM, Jatlaoui, TC, Tepper, NK et al. U.S. selected practice recommendations for contraceptive use, 2016. MMWR Recomm Rep 2016;65:1320.Google ScholarPubMed
American College of Obstetricians and Gynecologists. Increasing access to contraceptive implants and intrauterine devices to reduce unintended pregnancy. Committee Opinion No. 642. Obstet Gynecol 2015;126:e4448.CrossRef
Charlton, BM, Molgaard-Nielsen, D, Svanstrom, H et al. Maternal use of oral contraceptives and risk of birth defects in Denmark: prospective, nationwide cohort study. BMJ 2016; 352:h6712.CrossRefGoogle ScholarPubMed
Curtis, KM, Tepper, NK, Jatlaoui, TC et al. U.S. medical eligibility criteria for contraceptive use, 2016. MMWR Recomm Rep 2016;65:1104.Google ScholarPubMed
Callahan, R, Yacobson, I, Halpern, V, Nanda, K. Ectopic pregnancy with use of progestin-only injectables and contraceptive implants: a systematic review. Contraception 2015;92:514522.CrossRefGoogle ScholarPubMed
Raymond, EG, Waever, MA, Tan, Y et al. Effect of immediate compared with delayed insertion of etonogestrel implants on medical abortion efficacy and repeat pregnancy: a randomized controlled trial. Obstet Gynecol 2016;127:306312.CrossRefGoogle ScholarPubMed
Curtis, KM, Tepper, NK, Jatlaoui, TC et al. U.S. medical eligibility criteria for contraceptive use, 2016. MMWR Recomm Rep 2016;65(No.RR-3):1104.Google ScholarPubMed
Scarsi, KK, Darin, KM, Chappell, C et al. Drug-drug interactions, effectiveness, and safety of hormonal contraceptives in women living with HIV. Drug Saf 2016 November;39(11):10531072. Review.CrossRefGoogle ScholarPubMed
Haddad, LB, Tarleton, J, Sheth, AN, Ofotokun, I. Contraception for women living with HIV. In: Allen, RH and Cwiak, CA, eds. Contraception for the Medically Challenging Patient. New York, Springer Science+Business Media. 2014; 93117.Google Scholar
The Centers for Disease Control and Prevention. Effectiveness of Family Planning Methods. www.cdc.gov/reproductivehealth/unintendedpregnancy/pdf/contraceptive_methods_508.pdf. (Accessed May 1, 2017.)
Phillips, SJ, Polis, CB, Curtis, KM. The safety of hormonal contraceptives for women living with HIV and their sexual partners. Contraception 2016 January;93(1):1116. Review.CrossRefGoogle ScholarPubMed
Tepper, NK, Curtis, KM, Nanda, K, Jamieson, DJ. Safety of intrauterine devices among women with HIV: a systematic review. Contraception 2016 December;94(6):713724. Review.CrossRefGoogle ScholarPubMed
Tepper, NK, Steenland, MW, Garffield, ME et al. Retention of intrauterine devices in women who acquire pelvic inflammatory disease: a systematic review. Contraception 2013 May;87(5):655660. Review.CrossRefGoogle ScholarPubMed
Hatcher, RA, Trussel, J, Stewart, FH, et al. Contraceptive Technology, 20th rev ed. New York, Ardent Media, Inc.; 2011, 791792.Google Scholar
ACOG Committee Opinion no. 592: Sexual assault. Obstet Gynecol 2014;123(4): 905909.CrossRef
Black, MC, Basile, KC, Breiding, MJ et al. The National Intimate Partner and Sexual Violence Survey (NISVS): 2010 Summary Report. 2011, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention: Atlanta, GA.Google Scholar
Responding to Intimate Partner Violence and Sexual Violence against Women: WHO Clinical and Policy Guidelines. 2013: World Health Organization.
Workowski, KA, and Bolan, GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015;64(Rr-03):1137.Google ScholarPubMed
Ford, N, Mayer, KH. World health organization guidelines on postexposure prophylaxis for HIV: recommendations for a public health Approach. Clin Infect Dis 2015;60 Suppl 3: S161S164.CrossRefGoogle ScholarPubMed
Meites, E, Kempe, A, and Markowitz, LE. Use of a 2-Dose schedule for human papillomavirus vaccination – updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 2016;65(49):14051408.CrossRefGoogle ScholarPubMed
Curtis, KM, Tepper, NK, Jatlaoui, TC et al. U.S. medical eligibility criteria for contraceptive use, 2016. MMWR Recomm Rep 2016;65(No 3):1103.Google ScholarPubMed
Dehlendorf, C, Grumback, K, Schmittdiel, JA et al. Shared decision making in contraceptive counseling. Contraception 2017;95:452455.CrossRefGoogle ScholarPubMed
Society of Family Planning. Contraceptive considerations in obese women. Contraception 2009;80:583590.CrossRef
Grimes, DA, Shields, WC. Family planning for obese women: challenges and opportunities. Contraception 2005;72:14.CrossRefGoogle ScholarPubMed
Lopez, LM, Bernholc, A, Chen, M et al. Hormonal contraceptives for contraception in overweight or obese women. Cochrane Database Syst Rev 2016, Issue 8. Art No.: CD008452. DOI: 10.1002/14651858.CD008452.pub4.CrossRefGoogle ScholarPubMed
Dragoman, MV, Simmons, KB, Paulen, ME, Curtis, KM. Combined hormonal contraception (CHC) use among obese women and contraceptive effectiveness: a systematic review. Contraception 2017;95:117129.CrossRefGoogle ScholarPubMed
Yamazaki, M, Dwyer, K, Sobhan, M, Davis, D et al. Effect of obesity on the effectiveness of hormonal contraceptives: an individual participant data mega-analysis. Contraception 2015;92:445452.CrossRefGoogle Scholar
Dragoman, M, Petrie, K, Torgal, A, Thomas, T, Cremers, S, Westhoff, CL. Contraceptive vaginal ring effectiveness is maintained during 6 weeks of use: a prospective study of normal BMI and obese women. Contraception. 2013 Apr;87(4):432–6.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×